GLSI
Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. (GLSI) has 3 SEC Form 4 filings (5 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 30, 2026.
The most active filer is CEO and CFO Patel Snehal with 5 filings.
- Industry:Biotechnology
- CEO:Snehal S. Patel
- Employees:13
- HQ:Stafford, TX, US
- IPO:2020-09-25
Insider Buying
$97K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$187.9M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CEO and CFO | Purchase | 1,500 | $20K | Jul 30 | SEC ↗ | |
| CEO and CFO | Purchase | 700 | $9K | Jul 30 | SEC ↗ | |
| CEO and CFO | Purchase | 1,500 | $20K | Jul 29 | SEC ↗ | |
Patel SnehalFirst filing | CEO and CFO | Purchase | 2,500 | $33K | Jul 27 | SEC ↗ |
Patel SnehalFirst filing | CEO and CFO | Purchase | 1,100 | $14K | Jul 27 | SEC ↗ |
Related companies
Greenwich LifeSciences, Inc. is in the Healthcare sector.